Table 1 Patients’ characteristics at initial diagnosis
Variables | Low-CD33(n = 33) | High-CD33(n = 53) | P |
|---|---|---|---|
Sex(N,M/F) | 20/13 | 34/19 | 0.742 |
Age [Y,M (range)] | 44 (11–83) | 47 (16–86) | 0.457 |
WBC[109/L,M (range)] | 16.30 (0.8–145.2) | 54.66 (0.9–471.6) | 0.007 |
PLT[109/L,M (range)] | 58.71 (7.0–309.0) | 58.70 (3.0–275.0) | 1.000 |
primitive cell (%) | 46.64 (16.7–81.5) | 60.60 (7.5–98.8) | 0.005 |
FAB subtype (N,%) | 0.063 | ||
M0 | 0 (0) | 1 (1.9) | |
M1 | 0 (0) | 4 (7.5) | |
M2 | 27 (81.8) | 23 (43.4) | |
M4 | 5 (15.2) | 16 (30.2) | |
M5 | 1 (3.0) | 9 (17.0) | |
Karyotype | 0.027 | ||
Normal | 10 (30.3) | 29 (54.7) | |
Other | 23 (69.7) | 24 (45.3) | |
Gene | 0.114 | ||
Mutated | 25 (75.8) | 47 (88.7) | |
Non-Mutated | 8 (24.2) | 6 (11.3) | |
Induction chemotherapy | 0.775 | ||
CR (N,%) | 17 (51.5) | 29 (54.7) | |
NR (N,%) | 16 (48.8) | 24 (45.3) | |
Relapse or not (N,%) | 0.783 | ||
Yes | 15 (45.5) | 21 (39.6) | |
No | 18 (54.5) | 31 (58.5) | |
NA | 1 (1.9) | ||